Qikang Ying
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Apatinib inhibits HTNV by stimulating TFEB-driven lysosome biogenesis to degrade viral protein.
Journal: Antiviral research
Published: December 26, 2024
A Novel HTNV Budding Inhibitor Interferes the Interaction Between Viral Glycoprotein and Host ESCRT Accessory Protein ALIX.
Journal: Journal of medical virology
Published: July 04, 2024
T-cell immunoglobulin and mucin 1 (TIM-1) mediates infection of Hantaan virus in Jurkat T cells.
Journal: Virus research
Published: January 22, 2024
Guanylate-binding protein 1 inhibits Hantaan virus infection by restricting virus entry.
Journal: Journal of medical virology
Published: October 31, 2023
Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
Journal: Virus research
Published: March 09, 2023
In vitro Anti-Hantavirus Activity of Protein Kinase Inhibitor 8G1 Targeting AKT/mTOR/eIF4E Signaling Pathway.
Journal: Frontiers in microbiology
Published: February 21, 2022
Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.
Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses.
Journal: Frontiers in immunology
Published: January 10, 2022
Coumarin Derivative N6 as a Novel anti-hantavirus Infection Agent Targeting AKT.
Journal: Frontiers in pharmacology
Published: July 22, 2021
Nlrc3 Knockout Mice Showed Renal Pathological Changes After HTNV Infection.
Journal: Frontiers in immunology
Published: April 08, 2021
HTNV infection of CD8+ T cells is associated with disease progression in HFRS patients.
Journal: Communications biology
Published: September 09, 2020
Construction of lentivirus plasmid pCDH-NLRX1 and stable expression of NLRX1 in A549 cells
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: April 22, 2020
Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
Journal: Journal of medical microbiology
Published: January 19, 2019
Last Updated: 09/26/2026